Adalimumab +/- ciprofloxacin in perianal CD
Once versus three times daily dosing of oral budesonide for active Crohn’s disease: A double-blind, double-dummy, randomised trial
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Environmental factors in a population-based inception cohort of IBD patients in Europe — An ECCO-EpiCom study
Mode of Delivery and Risk of Inflammatory Bowel Disease in the Offspring: Systematic Review and Meta-analysis of Observational Studies
Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis
Polymorphisms of the vitamin D receptor gene and the risk of inflammatory bowel disease: a meta-analysis
A decrease of the butyrate-producing species *Roseburia hominis* and *Faecalibacterium prausnitzii* defines dysbiosis in patients with ulcerative colitis